Decheng Capital

Latest statistics and disclosures from Decheng Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are CGON, NUVB, AARD, ACRS, UPB, and represent 90.60% of Decheng Capital's stock portfolio.
  • Added to shares of these 1 stock: TNGX.
  • Started 1 new stock position in TNGX.
  • Reduced shares in these 4 stocks: RVMD (-$7.6M), NAMS (-$5.0M), KRYS, RCUS.
  • Sold out of its position in KRYS.
  • Decheng Capital was a net seller of stock by $-14M.
  • Decheng Capital has $732M in assets under management (AUM), dropping by 10.65%.
  • Central Index Key (CIK): 0002010850

Tip: Access up to 7 years of quarterly data

Positions held by Decheng Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Decheng Capital

Decheng Capital holds 14 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cg Oncology (CGON) 61.9 $453M 6.4M 71.05
 View chart
Nuvation Bio (NUVB) 20.1 $147M 26M 5.68
 View chart
Aardvark Therapeutics (AARD) 3.1 $23M 3.9M 5.76
 View chart
Aclaris Therapeutics (ACRS) 2.9 $21M 4.0M 5.29
 View chart
Upstream Bio (UPB) 2.6 $19M 2.7M 6.92
 View chart
Arcus Biosciences Incorporated (RCUS) 2.0 $14M -2% 465k 30.83
 View chart
Equillium (EQ) 1.9 $14M 4.4M 3.20
 View chart
Revolution Medicines (RVMD) 1.3 $9.9M -43% 53k 187.28
 View chart
Lyell Immunopharma 1.3 $9.7M 692k 14.05
 View chart
BeyondSpring SHS (BYSI) 0.9 $6.7M 3.8M 1.75
 View chart
Zentalis Pharmaceuticals (ZNTL) 0.9 $6.4M 1.3M 4.85
 View chart
Newamsterdam Pharma Co Nv (NAMS) 0.8 $6.0M -45% 177k 33.89
 View chart
Pyxis Oncology (PYXS) 0.1 $984k 327k 3.01
 View chart
Tango Therapeutics (TNGX) 0.1 $625k NEW 20k 31.26
 View chart

Past Filings by Decheng Capital

SEC 13F filings are viewable for Decheng Capital going back to 2023